Recro Pharma, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Malvern PA United States (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2014
NCT02169336
First Marketed Drug
2007
verapamil (calan)
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

RECRO GAINESVILLE | Recro Pharma, Inc.